Pitra Tomas, Pivovarcikova Kristyna, Alaghehbandan Reza, Bartos Vesela Adriena, Tupy Radek, Hora Milan, Hes Ondrej
Department of Urology, Faculty Hospital in Pilsen, Charles University in Prague, 30599 Pilsen, Czech Republic.
Sikl's Department of Pathology, Faculty Hospital in Pilsen, Charles University in Prague, 30599 Pilsen, Czech Republic.
Cancers (Basel). 2022 Feb 6;14(3):831. doi: 10.3390/cancers14030831.
Multilocular cystic renal neoplasm of low malignant potential (MCRNLMP) is a cystic renal tumor with indolent clinical behavior. In most of cases, it is an incidental finding during the examination of other health issues. The true incidence rate is estimated to be between 1.5% and 4% of all RCCs. These lesions are classified according to the Bosniak classification as Bosniak category III. There is a wide spectrum of diagnostic tools that can be utilized in the identification of this tumor, such as computed tomography (CT), magnetic resonance (MRI) or contrast-enhanced ultrasonography (CEUS). Management choices of these lesions range from conservative approaches, such as clinical follow-up, to surgery. Minimally invasive techniques (i.e., robotic surgery and laparoscopy) are preferred, with an emphasis on nephron sparing surgery, if clinically feasible.
低度恶性潜能多房性囊性肾肿瘤（MCRNLMP）是一种临床行为惰性的囊性肾肿瘤。在大多数情况下，它是在检查其他健康问题时偶然发现的。据估计，其真实发病率占所有肾细胞癌的1.5%至4%。这些病变根据博斯尼亚克分类法被归类为博斯尼亚克III类。有多种诊断工具可用于识别这种肿瘤，如计算机断层扫描（CT）、磁共振成像（MRI）或对比增强超声（CEUS）。这些病变的治疗选择范围从保守方法，如临床随访，到手术。如果临床可行，首选微创技术（即机器人手术和腹腔镜手术），重点是保留肾单位手术。
